Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.

about

Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.

Item

http://www.wikidata.org/entity/Q35651560

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Modified sequential therapy vs ...... s with Helicobacter infection.

@ast

Modified sequential therapy vs ...... s with Helicobacter infection.

@en

type

Item

label

Modified sequential therapy vs ...... s with Helicobacter infection.

@ast

Modified sequential therapy vs ...... s with Helicobacter infection.

@en

prefLabel

Modified sequential therapy vs ...... s with Helicobacter infection.

@ast

Modified sequential therapy vs ...... s with Helicobacter infection.

@en

P1476

Modified sequential therapy vs ...... s with Helicobacter infection.

@en

P2093

Bai-He Wu

http://www.w3.org/2001/XMLSchema#string

Gao-Hui Nong

http://www.w3.org/2001/XMLSchema#string

Jin-Qi Wei

http://www.w3.org/2001/XMLSchema#string

Mei-Zu Chen

http://www.w3.org/2001/XMLSchema#string

Xiao-Min Liao

http://www.w3.org/2001/XMLSchema#string

Xue-Ping Huang

http://www.w3.org/2001/XMLSchema#string

Yi-Ying Huang

http://www.w3.org/2001/XMLSchema#string

Yun-Yan Cong

http://www.w3.org/2001/XMLSchema#string

P2860

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication

Treatment of Helicobacter pylori infection: Past, present and future

Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment.

Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.

Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan.

Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis.

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.

Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection.

The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment.

P304

6310-6316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I20.6310

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277600040

http://www.w3.org/2001/XMLSchema#string

P698

26034367

http://www.w3.org/2001/XMLSchema#string

P932

4445109

http://www.w3.org/2001/XMLSchema#string